Home > Insider Trading > Filing (0001209191-14-032573)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1178253	Scynexis Inc	SCYX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1604069	Genavent F.c.p.r.	90 Boulevard Pasteur Cs 21564 Paris Cedex 15 I0 75730		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-05-07	5,251	$0.20	5,251	No	4	X	Direct
Common Stock	Acquisiton	2014-05-07	5,251	$0.20	10,502	No	4	X	Direct
Common Stock	Acquisiton	2014-05-07	3,501	$0.20	14,003	No	4	X	Direct
Common Stock	Acquisiton	2014-05-07	53,112	$0.00	67,115	No	4	C	Direct
Common Stock	Acquisiton	2014-05-07	96,921	$0.00	164,036	No	4	C	Direct
Common Stock	Acquisiton	2014-05-07	46,824	$0.00	210,860	No	4	C	Direct
Common Stock	Acquisiton	2014-05-07	16,738	$0.00	227,598	No	4	C	Direct
Common Stock	Acquisiton	2014-05-07	10,000	$10.00	237,598	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	X	Direct
No	4	X	Direct
No	4	X	Direct
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrant (right to buy)	Disposition	2014-05-07	5,251	$0.00	5,251	$0.20
Common Stock	Common Stock Warrant (right to buy)	Disposition	2014-05-07	5,251	$0.00	5,251	$0.20
Common Stock	Common Stock Warrant (right to buy)	Disposition	2014-05-07	3,501	$0.00	3,501	$0.20
Common Stock	Series B Preferred Stock	Disposition	2014-05-07	188,679	$0.00	53,112	$0.00
Common Stock	Series C Preferred Stock	Disposition	2014-05-07	342,726	$0.00	96,921	$0.00
Common Stock	Series D-1 Preferred Stock	Disposition	2014-05-07	955,215	$0.00	46,824	$0.00
Common Stock	Series D-2 Preferred Stock	Disposition	2014-05-07	341,456	$0.00	16,738	$0.00

Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2011-12-07	2016-12-06	No	4	X	Direct
2012-05-15	2017-05-14	No	4	X	Direct
2013-12-11	2018-12-10	No	4	X	Direct
		No	4	C	Direct
		No	4	C	Direct
		No	4	C	Direct
		No	4	C	Direct

Footnotes

Upon closing of the Issuer's initial public offering, each share of Series B Preferred Stock converted automatically into shares of common stock of the Issuer on a 1-for-3.536 basis, and had no expiration date.
Upon closing of the Issuer's initial public offering, each share of Series C Preferred Stock converted automatically into shares of common stock of the Issuer on a 1-for-3.536 basis, and had no expiration date.
Upon closing of the Issuer's initial public offering, each share of Series D-1 Preferred Stock converted automatically into shares of common stock of the Issuer on a 1-for-20.4 basis, and had no expiration date.
Upon closing of the Issuer's initial public offering, each share of Series D-2 Preferred Stock converted automatically into shares of common stock of the Issuer on a 1-for-20.4 basis, and had no expiration date.